The global allergic rhinitis drugs market is expected to grow at a CAGR of 3.3%

Wednesday, October 3, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Oct. 2, 2018 /PRNewswire/ -- Oral Antihistamines, Intranasal Corticosteroids, Intranasal Antihistamines, Immunotherapy and Vaccines

Read the full report: https://www.reportlinker.com/p04974738 The global allergic rhinitis drugs market is expected to grow at a CAGR of 3.3% in the first half of the forecast period. The market is estimated at $12.2bn
in 2017 and $14.3bn in 2022.How this report will benefit youRead on to discover how you can exploit the future business opportunities emerging in this sector.In this brand new 256-page report you will receive 97 tables and 100 figures- all unavailable elsewhere.The 256-page report provides clear detailed insight into the global allergic rhinitis drugs market. Discover the key drivers and challenges affecting the market.By ordering and reading our brand-new report today you stay better informed and ready to act.Report Scope- Global Allergic Rhinitis Drugs Market forecasts from 2018-2028- Along with revenue prediction for the overall world market for allergic rhinitis drugs, our investigation shows forecasts to 2028 for the following submarkets:- Intranasal Antihistamines- Intranasal Corticosteroids- Oral Antihistamines- Immunotherapy and Vaccines- How will leading allergic rhinitis drugs perform to 2028 at world level? Our study forecasts individual revenues of these 27 products:- Patanase- Astepro- Astelin- Dymista- Nasonex- Avamys- Veramyst- Flixonase- Rhinocort- Omnaris- Nasacort- Beconase- Qnasl- Zetonna- Allegra- Zyrtec- Claritin- Xyzal- Allelock- Clarinex- Ebastel- Talion- Staloral- Alutard SQ- Grazax- Ragwitek- Generic Azelastine- This report provides individual revenue forecasts to 2028 for these regional and national markets:- US- EU5 - Germany, UK, France, Italy and Spain- China- Japan- India- Russia- Brazil- Rest of the WorldEach national market is further segmented by submarket.- Our work provides analysis and sales forecast of the leading companies in the allergic rhinitis drugs market:- GlaxoSmithKline (GSK)- Merck & Co- Sanofi- Johnson & Johnson- ALK-Abello- UCB- Kyowo Hako Kirin- Stallergenes Greer- This report discusses the trends and development in the allergic rhinitis pipeline- Our study discusses strengths, weaknesses, opportunities and threats as well as porter's five forces analysis of the global allergic rhinitis drugs marketRead the full report: https://www.reportlinker.com/p04974738 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/the-global-allergic-rhinitis-drugs-market-is-expected-to-grow-at-a-cagr-of-3-3-300722884.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store